CF PharmTech, Inc. Raises USD $65 Million to Accelerate the Development of Company's Inhalation Products and Manufacturing Capacity to Global Market SUZHOU, China, August 28, 2017-- CF PharmTech, Inc. ("CF PharmTech"), a leading specialty pharmaceutical company that develops and manufactures inhalation products, announced today that it has raised $65M in a Series D financing. Future Industry Investment Fund, a private equity fund managed by SDIC Fund Management Corporation Limited ("SDIC Fund Management"), led the financing along with other prestigious healthcare investment groups in China.